Savara SVRA
NASDAQ SVRA
$4.99 +0.07 (+1.42%)
At close: Nov 11, 2026 · 4:00 PM EST

Savara (SVRA) Equity Income (2009 - 2014)

Updated

Analysis

Savara (SVRA) Equity Income (2009 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -19.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Savara 1.09 Bn 407.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 178,936.00
Dec 31, 2013 -357,872.00
Sep 30, 2013 178,936.00
Jun 30, 2013 178,936.00
Mar 31, 2013 178,936.00
Dec 31, 2012 -357,872.00
Sep 30, 2012 178,936.00
Jun 30, 2012 178,936.00
Mar 31, 2012 178,936.00
Dec 31, 2011 -357,872.00
Sep 30, 2011 178,936.00
Jun 30, 2011 178,936.00
Mar 31, 2011 178,936.00
Dec 31, 2010 -357,872.00
Sep 30, 2010 178,936.00
Jun 30, 2010 178,936.00
Mar 31, 2010 178,936.00
Sep 30, 2009 178,936.00
Jun 30, 2009 178,936.00
Mar 31, 2009 178,936.00
API Access

Savara Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=SVRA&period=max&api_key=YOUR_API_KEY